亚洲社会药学

Objective To find the shortcomings of children’s drug research and development policy in China, and to put forward feasible suggestions for encouraging China’s children’s drug research and development by drawing the experience from the United States. Methods To compare the similarities and differences between the policies guiding the use of children’s medicines issued by China and the United States. Results and Conclusion In recent years, the Chinese government has introduced a number of policies, but there is still a big gap in clinical trial design and drug review system compared with the policies of the United States. China should further improve the laws and regulations related to children’s medication, promote the development of clinical trials, develop pricing programs, and expand international cooperation, so as to formulate more scientific and comprehensive guiding principles for the research and development of children’s medication.